National Center for HIV STD and TB Prevention Report issue

Government Phase 1

Organization Overview

First Clinical Trial
2003
NCT00213044
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2003

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

carrageenan (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

HIV Infections (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1